Exchange: NYSE·Updated 02:11 PM EDT

SYK News

News
all
press releases
Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance?
J&J's shares fell 5.8% despite an earnings beat and raised guidance, as MedTech weakness, drug sales shortfalls and acquisition costs weighed on results.
Zacks
Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance?
J&J's shares fell 5.8% despite an earnings beat and raised guidance, as MedTech weakness, drug sales shortfalls and acquisition costs weighed on results.
Zacks
More News
Stryker launches Sonopet 3, delivering greater power and precision in ultrasonic tissue removal
Stryker launches Sonopet 3, delivering greater power and precision in ultrasonic tissue removal Stryker launches Sonopet 3, delivering greater power and precision in ultrasonic tissue removalPR NewswirePORTAGE, Mich., Oct. 14, 2026Stryker has received FDA 510(k) clearance for Sonopet 3 , the latest...
PR Newswire
Stryker To Invest In CMR Surgical; To Serve As U.S. Sales Agent For Versius Portfolio
(RTTNews) - Stryker (SYK) and CMR Surgical, a global robotics company, announced a strategic equity investment of approximately $400 million by Stryker with an exclusive option for Stryker to acquire the remaining equity of CMR Surgical, and an exclusive U.S. commercial agency ag...
Nasdaq News: Markets
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYKPR NewswireNEW YORK, Oct. 8, 2026NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is...
PR Newswire
Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Misses Revenue Estimates
Tilray Brands (TLRY) delivered earnings and revenue surprises of -68.42% and -1.98%, respectively, for the quarter ended August 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Stryker Stock In Focus As Truist Says CEO Transition Is Low-Risk, Cuts Price Target To $310
Stryker is preparing for a leadership transition as longtime CEO Kevin Lobo becomes Executive Chair, and Spencer Stiles takes over as CEO in January 2027.
Stocktwits
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?
J&J's MedTech faces Abiomed and competitive pressures, but Vision, Orthopedics and Surgery could drive a stronger second half.
Zacks
GEHC vs. SYK: Which Stock Should Value Investors Buy Now?
GEHC vs. SYK: Which Stock Is the Better Value Option?
Zacks
Stryker Now #115 Largest Company, Surpassing Vertiv Holdings
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Stryker Corp (Symbol: SYK) has taken over the #115 spot from Vertiv Holdings Co (Symbol: VRT), according to The Online Investor. Market capitalization is an important...
Nasdaq News: Markets
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSSPR NewswireSAN FRANCISCO, Oct. 1, 2026SAN FRANCISCO, Oct. 1, 2026 /PRNewswire/ -- On September 8...
PR Newswire

Advertisement|Remove ads.